Health Canada
NOTICE
Health Canada adopts new approach for in vitro dissolution data for additional strength biowaivers: Notice
Published: 10/29/2026Detected: 10/29/2026
Summary preview
Establishes a new policy approach for using in vitro dissolution data to support biowaivers for additional strengths of certain drugs.
Get the full analysis, free
Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.
Create free accountmanufacturing
quality
clinical
safety
labeling
#Health Canada
#biowaiver
#in vitro dissolution
#additional strength
#bioequivalence
Official Source Document Source Verified
Access the original document directly from HEALTH CANADA.
More from Health Canada
- Advisory Committee: Review of the Federal Approach to Pandemic Science Advice and Research Coordination10/29/2026
- Advisory Committee: National Pharmacare Committee of Experts10/29/2026
- Advisory Committee: Ministerial Advisory Council on Mental Health10/29/2026
- Advisory Committee: Expert Task Force on Substance Use10/29/2026
- Advisory Committee: Expert Panel on MAID and Mental Illness10/29/2026